ATARA BIOTHERAPEUTICS INC.
(Nasdaq: ATRA)
HEADQUARTERS: South San Francisco
BUSINESS: Biotherapeutics, T-cell immunotherapy
CEO: Pascal Touchon
MARKET CAP: $682.8 Million
Q1 EARNINGS: 2022 $7.31 Million
HEALTH CARE & BIOTECH
en-us
2022-07-04T07:00:00.0000000Z
2022-07-04T07:00:00.0000000Z
https://sfvbusinessjournal.pressreader.com/article/281719798278053
LABJ
